Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol. - Concepedia

Concepedia

Publication | Closed Access

Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol.

145

Citations

8

References

1995

Year

Charles D. Blanke, Rafat Ansari, R. Mantravadi, R Gonin, Roger Tokars, William B. Fisher, Kenneth Pennington, T. O'Connor, Susan M. Rynard, Michael E. Miller

Journal of Clinical Oncology

Abstract

Cisplatin, administered every 3 weeks, does not significantly improve response rate, progression-free survival, or overall survival when added to thoracic XRT for locally advanced unresectable NSCLC.

References

	Year	Citations

Page 1